Show Daily Example

Article

Show Daily Example

WOC Meeting Coverage sponsored by

and

Monday, February 20, 2006

Welcome

Welcome to Ophthalmology Times E-News, which will provide daily coverage of the 2006 World Ophthalmology Congress (WOC) in São Paulo, Brazil, Feb. 19 to 24.

Over the next several days, you will receive meeting coverage of the top clinical presentations, breaking industry news, latest new products, and other ophthalmic information.

On sight at WOC . . . The editors of Ophthalmology Times will roam the WOC meeting, gather the latest news and information, and deliver it daily to your inbox.

Check your e-mail throughout WOC for ?All the Clinical News in Sight? and more! Even if you are unable to attend the WOC meeting, it doesn't mean you have to miss out on the important news from São Paulo.

Do you have colleagues and associates who are not receiving Ophthalmology Times E-News? Have them log on to www.OphthalmologyTimes.com for the latest updates from WOC.

Finally, the staff of Ophthalmology Times would like to extend its thanks to Alcon Laboratories for sponsorship of this project.

World Congress unites ophthalmologists on knowledge quest

Feb. 19 ? São Paulo, Brazil ? More than 15,000 ophthalmologists from more than 110 countries are registered to attend, and more than 4,000 scientific papers were submitted for consideration. The schedule features more than 400 sessions in addition to subspecialty days, with some 2,400 speakers from all regions of the world.

All five major supranational ophthalmology societies?Afro-Asian Council of Ophthalmology, Asia-Pacific Academy of Ophthalmology, European Ophthalmological Society, Pan-American Association of Ophthalmology, and the Middle-East African Council of Ophthalmology?have contributed speakers and material, along with 61 subspecialty organizations and international groups.

In an effort to organize the sheer volume of material, the Congress will feature ? for the first time ? subspecialty days to focus on glaucoma, retina, cataracts, and cornea and refractive surgery.

WOC begins with forum on vision and blindness prevention

Feb. 19 ? São Paulo, Brazil ? The 2006 World Ophthalmology Congress (WOC) commenced in São Paulo, Brazil, on Sunday with the first Non-Governmental Organization (NGO) forum on vision and blindness prevention. The forum promoted the visibility of non-profit organizations that focus both on blindness prevention and assisting the visually impaired, contributing to an exchange of experiences between entities from all continents and from different socioeconomic realities, as well as organizing and providing a complete record of entities that cater to this area.

World Ophthalmology Congress opens

Feb. 19 ? São Paulo, Brazil ? For six days São Paulo, Brazil, will be the "Mecca" of ophthalmology. On Sunday, it was "get-acquainted day" as ophthalmic colleagues met to renew friendships with fellow colleagues and friends in industry. The Exhibit Hall opened late in the morning, drawing crowds of physicians to view the latest technology in ophthalmology.

Copyright 2006
Advanstar Communications
485 Route 1 South
Building F, 1st Floor
Iselin, NJ 08830

This email is part of an editorial product of Ophthalmology Times.
You have received this e-mail because you have elected to
subscribe to this email list. If you do not wish to receive emails
from Ophthalmology Times in the future, please follow the
unsubscribe information at the bottom of this message.
Or you may call 1-888-527-7008 between the hours
of 7:30AM and 5:00PM Central Time.

Ophthalmology Times E-News is published daily
during major Ophthalmology Meetings, and monthly
during the remainder of the year.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.